KRAS mutational status and sensitivity to a reversible epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in EGFR wild type (WT) advanced non-small cell lung cancer (NSCLC) patients (pts)

被引：0
|
作者：
Metro, Giulio [1 ]
Duranti, Simona [1 ]
Chiari, Rita [1 ]
Bennati, Chiara [1 ]
Molica, Carmen [1 ]
Curra, Maria Francesca [1 ]
Scafati, Chiara [1 ]
Siggillino, Annamaria [1 ]
Flacco, Antonella [1 ]
Marcomigni, Luca [1 ]
Ludovini, Vienna [1 ]
Minotti, Vincenzo [1 ]
Crino, Lucio [1 ]
机构：
[1] Azienda Osped Perugia, Dept Med Oncol, Santa Maria della Misericordia Hosp, Perugia, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18023
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Difference in incidence and pattern of salvage treatment after failure to first-line epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy and standard cytotoxic chemotherapy in pts with advanced non-small cell lung cancer (NSCLC) harboring EGFR mutations: Okayama Lung Cancer Study Group experience
    Kato, Yuka
    Ichihara, Eiki
    Hotta, Katsuyuki
    Hisamoto, Akiko
    Takigawa, Nagio
    Nogami, Naoyuki
    Kozuki, Toshiyuki
    Kudo, Kenichiro
    Tabata, Masahiro
    Shinkai, Tetsu
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] Intracavitary chemotherapy with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is not superior to TKI monotherapy in controlling malignant pleural effusion recurrence in EGFR-mutated lung cancer patients
    Wang, Wenxian
    Jiang, Xiaowen
    Zhang, Yiping
    Song, Yong
    Song, Zhengbo
    JOURNAL OF THORACIC DISEASE, 2019, 11 (09) : 3712 - 3720
  • [33] EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) CO-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AND RESPONSE TO EGFR TYROSINE KINASE INHIBITORS (TKIS)
    Barnet, Megan B.
    O'Toole, Sandra
    Horvath, Lisa' G.
    Selinger, Christina
    Yu, Bing
    Trent, Ronald
    Ng, Chiu Chin
    Boyer, Michael J.
    Cooper, Wendy
    Kao, Steven
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 156 - 156
  • [34] Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?
    Choi, Yong Won
    Choi, Jin-Hyuk
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (03): : 422 - 428
  • [35] Acquired resistance to an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in an uncommon G719S EGFR mutation
    Osoegawa, Atsushi
    Hashimoto, Takafumi
    Takumi, Yohei
    Abe, Miyuki
    Yamada, Tomonori
    Kobayashi, Ryoji
    Miyawaki, Michiyo
    Takeuchi, Hideya
    Okamoto, Tatsuro
    Sugio, Kenji
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (06) : 999 - 1005
  • [36] Acquired resistance to an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in an uncommon G719S EGFR mutation
    Atsushi Osoegawa
    Takafumi Hashimoto
    Yohei Takumi
    Miyuki Abe
    Tomonori Yamada
    Ryoji Kobayashi
    Michiyo Miyawaki
    Hideya Takeuchi
    Tatsuro Okamoto
    Kenji Sugio
    Investigational New Drugs, 2018, 36 : 999 - 1005
  • [37] MOLECULAR PROFILING OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) PATHWAY IN THE MANAGEMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS)
    Nuzzo, C.
    Sperduti, I.
    Marchetti, A.
    Cianciulli, A. M.
    Mottolese, M.
    Buttitta, F.
    Visca, P.
    Cecere, F. L.
    Cognetti, F.
    Milella, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 105 - 105
  • [38] Effectiveness Of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors On Non-Small Cell Lung Cancer Harboring Rare EGFR Mutations
    Chang, L. -C.
    Chen, K. -Y.
    Shih, J. -Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [39] Detection of drug resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) therapy in advanced non-small cell lung cancer (NSCLC) with functional (PET/CT) imaging.
    Bhoil, Amit
    Mittal, B. R.
    Singh, Navneet
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] TGFb expression as predictor of outcome in EGFR wild type (WT) metastatic non-small cell lung cancer (NSCLC) patients (PTS) treated with EGFR tyrosine kinase inhibitors (TKIs).
    Finocchiaro, Giovanna
    Toschi, Luca
    Gianoncelli, Letizia
    Canal, Barbara
    Rubino, Luca
    Lo Russo, Chiara
    Giordano, Laura
    Destro, Anna
    Garassino, Isabella
    Siracusano, Licia
    Cavina, Raffaele
    Roncalli, Massimo
    Carbone, Antonino
    Santoro, Armando
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345